The 7investing Podcast

7investing
undefined
Feb 17, 2021 • 1h 3min

Has Warren Buffett Lost His Touch?

Berkshire Buys Verizon and Chevron Shares. Has Warren Buffett Lost His Touch? The Oracle of Omaha has disclosed that his company has take stakes in Chevron and Verizon. These aren’t exactly bold moves and they won’t convince anyone that the one-time genius may have lost something off his fastball. Has Berkshire Hathaway lost its way and is its leader out of touch with current markets? Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 16, 2021 • 49min

7investing and CryptoEQ: Tesla, Bitcoin, and Coinbase Going Public

7investing and CryptoEQ recently announced a partnership, to help investors get a better consolidated view of the opportunities in both equities and in cryptocurrencies. 7investing provides its top seven stock market recommendations every month, while CryptoEQ provides its top-rated cryptocurrencies. The two companies are now joining forces on a monthly basis, to discuss the most important recent developments taking place and the impact they'll have on both equities and crypto. This past month, that conversation included a discussion about Tesla's "audacious" commitment to buy $1.5 billion worth of Bitcoin for its corporate treasury, as well as Coinbase coming public at a valuation of up to $75 billion. Going forward, 7investing will publish the full video of these conversations to subscribers as a monthly Advisor Update. CryptoEQ will publish a written recap of the conversation with additional context in their monthly subscriber email newsletter. We've also decided that we'll be providing this first episode for free! We hope you enjoy the show and our takeaways as a part of our 7investing podcast series. If you'd like to gain access future shows, please consider becoming a subscriber by visiting 7investing.com/subscribe or cryptoeq.io/#memberships Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 15, 2021 • 1h 1min

How to Build a Long-term Investing Mindset

We’ve heard a lot recently about how the individual investor can’t compete with the big guys and hedge funds. That’s true when it comes to being a trader -- you can’t beat the computers and the big money. The little guy, however, has one advantage, time. Being a long-term investor can bring incredible returns but it takes patience. It’s not easy for everyone to deal with the ups and downs of the market but if you buy-and-hold good companies you will make money in the long run. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 12, 2021 • 1h

Walt Disney Earnings and the MIT Conference

It has been a mixed pandemic for the Walt Disney Company. The Mouse House has seen its theatrical business go away and its theme parks operate at limited capacities or not be able to open at all. On the positive side, the company’s streaming platforms have shown explosive growth which led to some surprising first quarter results. In addition, Simon Erickson will update us on the MIT Conference and Matt Cochrane will tell everyone about the $75 billion company you may never have heard of. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 11, 2021 • 41min

A Return to a Margin of Safety with Brett Schafer and Ryan Henderson

While backup kickers on the Washington State University football team, Brett Schafer and Ryan Henderson used to spend down time talking about stocks. This mutual interest soon blossomed into a regular podcast and website. The first year after they began, Schafer and Henderson report, it was mostly just friends and family listening. But as they began interviewing financial analysts and writers from around the Twitterverse, they quickly gained an audience with their unique blend of youthful humor, hot takes on the market, and solid investment analysis.    The pair are now launching a new fund, Arch Capital. For every position that made it into the portfolio, the pitch ended with the same two questions:    1)Over the next 3-5 years, what are the chances this investment loses money?   2) What chance do you give this stock, at current prices, to compound at 15% over the next 3-5 years?   As Schafer and Henderson like to say, "We start with a margin of safety, and end with growth." The end result is a portfolio with a nice mix of value, growth, and income names. And video games. A lot of video games. In the interview, both Schafer and Henderson talk a little about the video game industry before breaking down one of their top holdings, Nintendo (OTC:NTDOY), a company that probably gets far too less love from American investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 10, 2021 • 23min

Under Armour Earnings and Story Stocks

Under Armour reported a surprise profit and stong online sales. That bodes well but it does not necessarily mean that the company has turned the corner. Steve Symington joins Dan Kline to discuss. In our second segment, Maxx Chatsko jumps on to talk about “story stocks” and why they’re usually not a great idea. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 9, 2021 • 48min

Improving Your Decision-Making Process with Krzysztof Piekarski

Investing is equal parts of analytical research and behavioral science. University of Texas professor Krzysztof Piekarski explains how investors can be aware of their biases to improve their decision-making process. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 8, 2021 • 1h 1min

Super Bowl Commercials + 3 Big Questions on EV

The big game was yesterday! Which means it’s time to discuss the most important part of the Super Bowl to many – the commercials! Which Super Bowl ads made the biggest impact? Tune in to hear the team’s take, as well as listen as we answer the 3 biggest questions about electric vehicles. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 4, 2021 • 46min

Navigating Next-Generation Cellular Therapies

The first chimeric antigen T-Cell Therapy (CAR-T) therapies were approved by the Federal Drug Administration (FDA) in 2017--these were heralded as “cures” for blood-borne cancers such as acute myeloid leukemia and aggressive non-Hodgkin’s Lymphoma. Here, we have Simon Harnest, the Senior Vice President of Corporate Strategy and Finance of Cellectis (CLLS), unpacking where cell therapy is headed towards. Cellectis is the first company  to envision an “off-the-shelf” approach to CAR-T therapy. Previous methods required long manufacturing times and complex methodologies to create a single treatment for a patient.  In this episode, Simon guides us through the complexities of creating an allogeneic approach for developing CAR-T therapies, especially for solid tumors, and addresses why Cellectis is up for the challenge. He also addresses the discrepancy between current valuations of Cellectis and competitor, Moderna (MRNA) who happens to license from Cellectis. This podcast is for anyone interested in learning about the nitty gritty of next generation cancer care from the bottom-up perspective.  Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing
undefined
Feb 4, 2021 • 56min

Amazon’s CEO Jeff Bezos Steps Down and Your Investing Questions Answered

Jeff Bezos will step down as Amazon CEO and move into an executive chairman role. Andy Jassy, who has headed up the company’s AWS cloud division will become the news boss. What does this mean for investors and will anything really change? We’ll also be digging into the numbers as the company reported strong earnings after the market closed Tuesday.. We’re also taking your questions on pretty much any investing topic. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app